Ausgabe 4/2010
Inhalt (15 Artikel)
Regulation of immunity and oncogenesis by the IRF transcription factor family
David Savitsky, Tomohiko Tamura, Hideyuki Yanai, Tadatsugu Taniguchi
CD4+CD45RA+CXCR4+ lymphocytes are inversely associated with progression in stages I–III melanoma patients
Maria Napolitano, Alessandro Ottaiano, Francesca Mauro, Caterina Ieranò, Rocco Satriano, Roberto Pacelli, Renato Franco, Valentina De Angelis, Giuseppe Castello, Stefania Scala
A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells
Sofía Grille, Andreína Brugnini, Martha Nese, Esteban Corley, Frank W. Falkenberg, Daniela Lens, José A. Chabalgoity
Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer
Barbara Seliger, Robert Stoehr, Diana Handke, Anja Mueller, Soldano Ferrone, Bernd Wullich, Andrea Tannapfel, Ferdinand Hofstaedter, Arndt Hartmann
Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model
Christian Ginzkey, Sven O. Eicker , Matthias Marget, Joerg Krause, Stephan Brecht, Manfred Westphal, Hans H. Hugo, H. M. Mehdorn, Joerg Steinmann, Wolfgang Hamel
Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer
Rodolfo Passalacqua, Carlo Buzio, Sebastiano Buti, Camillo Porta, Roberto Labianca, Debora Pezzuolo, Roberta Camisa, Roberto Sabbatini, Luigi Benecchi, Caterina Messina, Rita Cengarle, Augusto Vaglio, Matteo Dalla Chiesa, Gianluca Tomasello, Caterina Caminiti
Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties
Bhavna Verma, Oriana E. Hawkins, Francisca A. Neethling, Shannon L. Caseltine, Sherly R. Largo, William H. Hildebrand, Jon A. Weidanz
FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release
Johannes Rolin, Kristin L. Sand, Eirunn Knudsen, Azzam A. Maghazachi
Type I interferons inhibit the generation of tumor-associated macrophages
Lance U’Ren, Amanda Guth, Debra Kamstock, Steven Dow
Homeostasis of peripheral FoxP3+ CD4+ regulatory T cells in patients with early and late stage breast cancer
Andrew J. Rech, Rosemarie Mick, David E. Kaplan, Kyong-Mi Chang, Susan M. Domchek, Robert H. Vonderheide
Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells
Sylvia Janetzki, L. Price, C. M. Britten, S. H. van der Burg, J. Caterini, J. R. Currier, G. Ferrari, C. Gouttefangeas, P. Hayes, E. Kaempgen, V. Lennerz, K. Nihlmark, V. Souza, A. Hoos
Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program
A. Mander, C. Gouttefangeas, C. Ottensmeier, M. J. P. Welters, L. Low, S. H. van der Burg, C. M. Britten
Effective adoptive therapy of tap-deficient lymphoma using diverse high avidity alloreactive T cells
Zoran Popmihajlov, Fabio R. Santori, Daniel Gebreselassie, Anthony D. Sandler, Stanislav Vukmanovic
ESCII–PIVAC meeting “Recent advances in cancer immunotherapy with an emphasis on cancer vaccines” held in Athens, 9–11 October 2008
Viktor Umansky, Barbara-ann Guinn
Erratum to: A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo
Jianxin Dai, Bohua Li, Jinping Shi, Ling Peng, Dapeng Zhang, Weizhu Qian, Sheng Hou, Lei Zhao, Jie Gao, Zhiguo Cao, Jian Zhao, Hao Wang, Yajun Guo